Brief: Bausch + Lomb Announces Publication Of Data From A Prospective Study Evaluating Efficacy Of Xiidra
09/09/2025 12:40
Sept 9 (Reuters) - Bausch + Lomb Corp BLCO.TO: BAUSCH + LOMB ANNOUNCES PUBLICATION OF DATA FROM A PROSPECTIVE STUDY EVALUATING THE EFFICACY OF XIIDRA® IN ALLEVIATING DISCOMFORT IN SYMPTOMATIC CONTACT LENS WEARERS Source text: ID:nBw2mHbvBa Further company coverage: BLCO.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser